Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.60
-0.21 (-3.61%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $965.62 million as of March 10, 2026. Its market cap has increased by 72.72% in one year.
Market Cap
965.62M
Enterprise Value
1.11B
1-Year Change
72.72%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $965.62M, an increase of 226.47%. That is a compound annual growth rate of 30.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 965.62M | -25.86% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 1.06B |
| AbCellera Biologics | 1.05B |
| ArriVent BioPharma | 1.04B |
| Inhibrx Biosciences | 1.01B |
| UroGen Pharma | 996.04M |
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |
| Aktis Oncology | 987.94M |